Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Sep-24 5:46 PM View:  | Relmada Therapeutics, Inc. (RLMD) | 11-Sep-24 | Purchase | 24,120 | $2.95 | $71,154.00 | 38% 64.22K to 88.33K | |
| 11-Sep-24 5:46 PM View: | Relmada Therapeutics, Inc. (RLMD) | 10-Sep-24 | Purchase | 21,118 | $2.73 | $57,652.10 | 49% 43.1K to 64.22K | |
| 11-Sep-24 5:46 PM View: | Relmada Therapeutics, Inc. (RLMD) | 09-Sep-24 | Private Purchase | 8,194 | $2.55 | $20,894.70 | 23% 34.9K to 43.1K | |
| 31-Jan-24 6:28 PM View: | Relmada Therapeutics, Inc. (RLMD) | 31-Jan-24 | Purchase | 6,875 | $4.06 | $27,943.40 | 25% 28.03K to 34.9K | |
| 31-Jan-24 6:28 PM View: | Relmada Therapeutics, Inc. (RLMD) | 30-Jan-24 | Purchase | 15,000 | $3.89 | $58,323.00 | 115% 13.03K to 28.03K | |
| 31-Jan-24 6:28 PM View: | Relmada Therapeutics, Inc. (RLMD) | 29-Jan-24 | Private Purchase | 10,800 | $3.65 | $39,450.20 | 485% 2.23K to 13.03K | |
| 10-Mar-21 6:18 PM View: | Relmada Therapeutics, Inc. (RLMD) | 10-Mar-21 | Market Option Sale (Planned) | 2,373 | $35.11 | $83,313.40 | (52%) 4.6K to 2.23K | |
| 10-Mar-21 6:18 PM View: | Relmada Therapeutics, Inc. (RLMD) | 09-Mar-21 | Market Option Sale (Planned) | 7,527 | $35.56 | $267,693.00 | (62%) 12.13K to 4.6K | |
| 10-Mar-21 6:18 PM View: | Relmada Therapeutics, Inc. (RLMD) | 08-Mar-21 | Option Exercise | 10,000 | $3.24 | $32,400.00 | 449% 2.23K to 12.23K | |
| 10-Mar-21 6:18 PM View: | Relmada Therapeutics, Inc. (RLMD) | 08-Mar-21 | Market Option Sale (Planned) | 100 | $35.00 | $3,500.00 | (< 1%) 12.23K to 12.13K | |
| 26-Feb-21 4:48 PM View: | Relmada Therapeutics, Inc. (RLMD) | 24-Feb-21 | Option Exercise | 3,000 | $3.24 | $9,720.00 | 135% 2.23K to 5.23K | |
| 26-Feb-21 4:48 PM View: | Relmada Therapeutics, Inc. (RLMD) | 24-Feb-21 | Market Option Sale (Planned) | 3,000 | $34.18 | $102,529.00 | (57%) 5.23K to 2.23K | |
| 16-Feb-21 5:08 PM View: | Relmada Therapeutics, Inc. (RLMD) | 11-Feb-21 | Option Exercise | 1,428 | $3.24 | $4,626.72 | 64% 2.23K to 3.66K | |
| 16-Feb-21 5:08 PM View: | Relmada Therapeutics, Inc. (RLMD) | 11-Feb-21 | Market Option Sale (Planned) | 1,428 | $35.39 | $50,542.10 | (39%) 3.66K to 2.23K | |
| 10-Feb-21 7:25 PM View: | Relmada Therapeutics, Inc. (RLMD) | 10-Feb-21 | Market Option Sale (Planned) | 2,410 | $35.20 | $84,825.50 | (52%) 4.64K to 2.23K | |
| 10-Feb-21 7:25 PM View: | Relmada Therapeutics, Inc. (RLMD) | 09-Feb-21 | Market Option Sale (Planned) | 5,359 | $35.24 | $188,843.00 | (54%) 10.0K to 4.64K | |
| 10-Feb-21 7:25 PM View: | Relmada Therapeutics, Inc. (RLMD) | 08-Feb-21 | Option Exercise | 11,372 | $3.24 | $36,845.30 | 510% 2.23K to 13.6K | |
| 10-Feb-21 7:25 PM View: | Relmada Therapeutics, Inc. (RLMD) | 08-Feb-21 | Market Option Sale (Planned) | 3,603 | $35.04 | $126,242.00 | (26%) 13.6K to 10.0K | |
| 04-Feb-21 5:38 PM View: | Relmada Therapeutics, Inc. (RLMD) | 03-Feb-21 | Market Option Sale (Planned) | 100 | $35.00 | $3,500.00 | (4%) 2.33K to 2.23K | |
| 04-Feb-21 5:38 PM View: | Relmada Therapeutics, Inc. (RLMD) | 02-Feb-21 | Option Exercise | 3,200 | $3.24 | $10,368.00 | 144% 2.23K to 5.43K | |
| 04-Feb-21 5:38 PM View: | Relmada Therapeutics, Inc. (RLMD) | 02-Feb-21 | Market Option Sale (Planned) | 3,100 | $35.04 | $108,634.00 | (57%) 5.43K to 2.33K | |
| 29-Jan-21 5:24 PM View: | Relmada Therapeutics, Inc. (RLMD) | 27-Jan-21 | Option Exercise | 3,000 | $3.24 | $9,720.00 | 135% 2.23K to 5.23K | |
| 29-Jan-21 5:24 PM View: | Relmada Therapeutics, Inc. (RLMD) | 27-Jan-21 | Market Option Sale (Planned) | 3,000 | $31.93 | $95,778.00 | (57%) 5.23K to 2.23K | |
| 26-Jan-21 7:28 PM View: | Relmada Therapeutics, Inc. (RLMD) | 26-Jan-21 | Market Option Sale (Planned) | 607 | $35.16 | $21,342.10 | (21%) 2.83K to 2.23K | |
| 26-Jan-21 7:28 PM View: | Relmada Therapeutics, Inc. (RLMD) | 25-Jan-21 | Market Option Sale (Planned) | 1,280 | $35.27 | $45,145.60 | (31%) 4.12K to 2.83K | |
| 26-Jan-21 7:28 PM View: | Relmada Therapeutics, Inc. (RLMD) | 22-Jan-21 | Option Exercise | 4,000 | $324.00 | $1,296,000.00 | 180% 2.23K to 6.23K | |
| 26-Jan-21 7:28 PM View: | Relmada Therapeutics, Inc. (RLMD) | 22-Jan-21 | Market Option Sale (Planned) | 2,113 | $35.55 | $75,124.00 | (34%) 6.23K to 4.12K | |
| 21-Oct-19 4:23 PM View: | Relmada Therapeutics, Inc. (RLMD) | 21-Oct-19 | Market Purchase | 978 | $23.00 | $22,494.00 | 78% 1.25K to 2.23K | 40% |
| 02-Jan-19 6:44 PM View: | Entero Therapeutics, Inc. (ENTO) | 28-Dec-18 | Market Purchase | 20,000 | $1.31 | $26,214.00 | 47% 42.5K to 62.5K | (72%) |
| 23-Oct-17 5:43 PM View: | Entero Therapeutics, Inc. (ENTO) | 19-Oct-17 | Grant | 22,500 | -- | -- | 112% 20.0K to 42.5K | |
| 07-Jan-16 6:22 PM View: | Protea Biosciences Group, I... (NONE) | 18-Dec-15 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 17-Dec-15 9:37 AM View: | Relmada Therapeutics, Inc. (RLMD) | 15-Dec-15 | Market Purchase | 3,000 | $2.99 | $8,957.59 | 150% 2.0K to 5.0K | 158% |
| 16-Dec-15 4:23 PM View: | Relmada Therapeutics, Inc. (RLMD) | 14-Dec-15 | Market Purchase | 2,000 | $2.89 | $5,780.00 | 100% 0 to 2.0K | 166% |